12915561.txt 0 identification   novel immunodominant cd4 th1type  cell peptide epitopes   herpes simplex virus glycoprotein     confer protective immunity
12915561.txt 1   molecular characterization     epitope repertoire   herpes simplex virus hsv antigens would greatly expand   knowledge   hsv immunity   improve immune interventions against herpesvirus infections hsv glycoprotein   gd   an immunodominant viral coat protein     considered an excellent vaccine candidate antigen   using   tepitope prediction algorithm   have identified   characterized   total   12 regions within   hsv type 1 hsv1 gd bearing potential cd4  cell epitopes each 27   34 amino acids   length immunogenicity studies     corresponding mediumsized peptides confirmed   previously known gd epitopes   additionally revealed four new immunodominant regions gd4982 gd146179 gd228257   gd332358 each containing naturally processed epitopes these epitopes elicited potent  cell responses   mice   diverse major histocompatibility complex backgrounds each     four new immunodominant peptide epitopes generated strong cd4 th1   cells   were biologically active against hsv1infected bone marrowderived dendritic cells importantly immunization   h2d mice     four newly identified cd4 th1 peptide epitopes       four cd4 th2 peptide epitopes induced   robust protective immunity against lethal ocular hsv1 challenge these peptide epitopes may prove     important components   an effective immunoprophylactic strategy against herpes
12915561.txt 2 
12915561.txt 3 genitaldermal   ocular herpes simplex virus hsv infections cause prevalent lifelong recurrent infections     spectrum   clinical manifestations including cold sores genital lesions corneal blindness   encephalitis  despite   availability   many interventional strategies   has been   constant increase   hsv prevalence during   last 3 decades  several challenges face   development   an effective herpes vaccine   could help control   epidemic including   uncertainty about   exact immune correlates   protection   identification   immunogenic epitopes     development   an effective   safe immunization strategy  despite previous emphasis   antibody ab   cd8  cell responses      growing evidence   support   pivotal role      helper type 1 th1 subset   cd4   cells   antiherpesvirus immunity  cd4   cells   required     protection   mice   hsv challenge    humans cd4   cells   stimulated   vivo following an hsv infection     integrated cd4 memory response   hsv type 1 hsv1 appears   occur   up   02   circulating cd4   cells  severe herpetic infections   often seen   immunocompromised individuals   impaired  cell immunity such   aids   transplant patients where   immune defect   predominantly displayed   cd4   cells  while     believed   cd4  cell responses   important   protection   general   importance   th1 versus th2type immune responses   protection against hsv1 infection   still under investigation these findings along     important role   cd4 cells   supporting both bcell   cd8  cell functions  suggest     successful immunotherapeutic   immunoprophylactic strategy against hsv1 should include immunodominant cd4 thcell epitopes  several lines   evidence point   glycoprotein   gd being   major target   hsv1 immune clearance mechanisms   therefore an excellent candidate antigen ag       highly conserved   antigenically crossreactive   hsv1   hsv2  ii     among   main target ags   cd4   cells   hsvseropositive individuals  iii   appears   play   vital role   initiating   infectious process    iv importantly   recent large human genital hsv clinical trial shows   immunization   gd recombinant protein mixed   alum   3 deacylatedmonophosphoryl lipid   adjuvants induced significant protection against clinically apparent genital herpes   women who were seronegative   both hsv1   hsv2    gd epitopes     immune mechanism   provide protective immunity     yet fully understood knowledge   immune responses   gd     their correlation   protection   limited primarily     identification   bcell epitopes    only   limited number    cell epitopes having been reported   date    hypothesized   characterization     cd4  cell epitope repertoire   gd could   vital     case   hsv infection after infection cd4   cells directed     immunodominant epitopes   gd might have been inactivated     cells specific   subdominant epitopes might have escaped  cell tolerance    present study was aimed   identifying   cd4  cell epitopes   hsv1 gd   determining   role   cd4 th1 versus cd4 th2  cell epitopes   protection against an ocular hsv1 challenge   analyzed hsv1 gd   cd4  cell epitopes     combined approach   computational identification   candidate  cell epitopes followed     vitro     vivo biologic validation many     predicted gd sequences were established   forming natural epitopes recognized   hsv1primed cd4   cells   their   vivo function was confirmed   inducing   cd4dependent protective immunity against hsv challenge among 12 predicted gd sequences   found four new immunodominant peptide epitopes gd4982 gd146179 gd228257   gd332358 containing naturally processed epitopes   selectively induced   strong th1 subset   cd4   cells   mice four other epitope peptides gd2252 gd77104 gd200234   gd287317 were found   preferentially induce   th2 subset   cd4   cells interestingly immunization     newly identified immunodominant cd4 th1 peptide epitopes     cd4 th2 peptide epitopes induced cd4dependent protective immunity against lethal hsv1 challenge   peptide epitopes described     report could form part   an immunotherapeutic   an immunoprophylactic strategy   treating herpes
12915561.txt 4  cell epitope prediction    gd sequence hsv1 strain 17 was loaded into   new prediction software tepitope   predict promiscuous epitopes    tepitope algorithm     windows application     based   25 quantitative matrixbased motifs   cover   significant part   human hla class ii peptide binding specificity    algorithm permits   prediction   parallel display   ligands   each     25 hladr alleles   tepitope prediction threshold was set   5   12 regions  predicted   bind   least 50     major histocompatibility complex mhc class ii molecules were picked   peptide gd253278 lppelsetpnatqpelapedpedsal     region gd257287     peptide gb728761 naamfaglgaffegmgdlgravgkvvmgivggvv   were   picked     tepitope program   containing potential  cell epitopes were synthesized   were used   negative controls  synthesis   peptides    total   14 peptides 12 gd tepitopeselected peptides   2 control peptides   selected   tepitope  e gd253278   gb728761 each consisting   27   34 amino acids were synthesized   biosource international hopkinton mass     9050 pep synthesizer instrument   using solidphase peptide synthesis   standard 9fluorenylmethoxy carbonyl technology pe applied biosystems foster city calif peptides were cleaved     resin   using trifluoroacetic acidanisolethioanisoleanisoleethanedithiol edtwater 8752525255 followed   ether methyl butyl ether extraction   lyophilization   previously described    purity   peptides was between 75   96   determined   reversedphase highperformance liquid chromatography vydac c18   mass spectroscopy voyager malditof system stock solutions were made   1 mgml   water except   peptide gd146179   was solubilized   5 dimethyl sulfoxide   peptides were aliquoted   were stored   20c until assayed   studies were conducted     immunogen emulsified   montanideisa720 adjuvant misa720 seppic fairfield nj     3070 ratio   was immediately injected   mice  hsv1    mckrae strain   hsv1 was used     study   virus was triple plaque purified   was prepared   previously described  uvinactivated hsv1 was made   exposing   live virus     philips 30w uv bulb   10 min     distance   5 cm heatkilled virus was made   heating virus solution   100c   5 min hsv inactivation was confirmed     inability   produce plaques when tested   vero cells  mice   immunization  six   8weekold c57bl6 h2b balbc h2d   c3hhej h2k mice purchased     jackson laboratory bar harbor maine were used     experiments groups   five mice per strain were immunized subcutaneously   peptides   misa720 adjuvant   days 0   21  peptidespecific  cell assay  twelve days after   second immunization spleen   inguinal lymph nodes were removed   placed   icecold serumfree hl1 medium supplemented   15 mm hepes 5 x 105 m betamercaptoethanol 2 mm glutamine 50 u   penicillin   50 mug   streptomycin gibcobrl grand island ny cm    cells were cultured   96well plates   5 x 105 cellswell   cm   recall   control peptide     30 10 3 1   03mugml concentration   previously described    cell suspensions were incubated   72 h   37c   5 co2 one microcurie   3hthymidine dupont nen boston mass was added   each well during   last 16 h   culture   incorporated radioactivity was determined   harvesting cells onto glass fiber filters   counting     matrix 96 direct ionization counter packard instruments meriden conn  results were expressed     mean counts   cellassociated 3hthymidine per minute recovered   wells containing ag minus   mean counts   cellassociated 3hthymidine per minute recovered   wells without ag deltacpm average   triplicate   stimulation index si was calculated     mean counts   cellassociated 3hthymidine per minute recovered   wells containing ag divided     mean counts   cellassociated 3hthymidine per minute recovered   wells without ag average   triplicate     experiments   irrelevant control peptide gb141165      cell mitogen concanavalin   sigma st louis mo were used   negative   positive controls respectively proliferation results were confirmed   repeating each experiment twice    cell proliferative response was considered positive when deltacpm was  1000   when   si was  2   previously reported   cd4   cd8 blocking    cell responses  mice were immunized     gd peptide   splenocytes were isolated   stimulated   described above stimulated splenocytes were   incubated     immunizing   control peptide     without   anticd4 monoclonal ab mab gk15 pharmingen san diego calif identically prepared cultures were incubated   anticd8 mab 5367 pharmingen     an isotypematched control ab     10 mugml   has been previously shown   these antibodies show   expected specificities   function   expected   cytokine analysis    cells were stimulated   either immunizing peptides 10 mugml   irrelevant control peptide 10 mugml uvinactivated hsv1 multiplicity   infection moi  3     concanavalin   05 mugml     positive control culture media were harvested   48 h   interleukin 2 il2   96 h   il4   gamma interferon ifngamma   were analyzed   specific sandwich enzymelinked immunosorbent assay following   manufacturers instructions pharmingen  flow cytometry analysis  gd peptidestimulated   cells were phenotyped   double staining   anticd4   anticd8 mabs   fluorescenceactivated cell sorter analysis after 4 days   stimulation     10 mum concentration   each peptide 106 cells were washed   cold phosphatebuffered saline2 bovine serum albumin buffer   were incubated   phycoerythrin anticd4 pharmingen     fluorescein isothiocyanate anticd8 pharmingen mabs   20   30 min   ice propidium iodide was used   exclude dead cells   each sample 20000 events were acquired     facscalibur   were analyzed   cellquest software   an integratedpower macintosh g4 becton dickinson san jose calif  bone marrowderived dc  murine bone marrowderived dendritic cells dc were generated   using   modified version     protocol   was described previously  briefly bone marrow cells were flushed   tibias   femurs   rpmi 1640     singlecell suspension was made   total   2 x 106 cells were cultured   100mm tissue dishes containing 10 ml   rpmi 1640 supplemented   2 mm glutamine 1 nonessential amino acids gibcobrl 10 fetal calf serum 50 ng   granulocytemacrophage colonystimulating factor per ml   50 ng   il4 peprotech inc per ml cells were fed   fresh media supplemented   25 ng   granulocytemacrophage colonystimulating factor per ml   25 ng   il4 per ml every 72 h after 7 days   incubation   protocol yielded 50 x 106   60 x 106 cells   70   90     nonadherent cells having typical dc morphology   was routinely confirmed   fluorescenceactivated cell sorter analysis   cd11c class ii   dec205 surface markers   dc  cd4 cell responses   hsvinfected dc  cd4  cell lines specific   each     gd peptides were derived   spleens   immunized mice   vitro   previously described    test   biological relevance   these peptide epitopes cd4  cell effector cells were incubated   irradiated dc  cell dc ratio  501 infected   uvinactivated hsv1 moi   3 1 03   01   lipopolysaccharide 1 mgml matured   24 h     control cd4   cells were also incubated   mockinfected dc dc   cd4   cells were incubated   5 days   37c 3hthymidine was added     cultures 18 h before harvesting proliferative responses were tested   quadruplicate wells     results were expressed   mean counts per minute  standard deviation   some experiments splenocytes   immunized   control mice were restimulated   vitro   incubation   heatinactivated   uvinactivated hsv1    vivo depletion   cd4   cd8   cells   hsv1 challenge  twenty days after   second dose   peptide immunogens mice were infected   2 x 105 pfu per eye   hsv1   tissue culture media administered   eyedrops     volume   10 mul   some experiments immunized mice were intraperitoneally injected   six doses   01 ml   clarified ascetic fluid   05 ml   phosphatebuffered saline containing mab gk15 anticd4   mab 243 anticd8   days 7 1 0 2   5 postinfection flow cytometry analysis   spleen cells consistently revealed   decrease   cd4   cd8   cells   treated mice   levels   3   those   normal mice  statistical analysis  figures represent data   two   three independent experiments   data   expressed     mean  standard error     mean   were compared   using students   test     statview ii statistical program abacus concepts berkeley calif
12915561.txt 5 prediction   potential hsv1 gd  cell epitopes     tepitope algorithm    deduced primary amino acid sequence     hsv1 glycoprotein gd was analyzed     newly developed  cell epitope prediction tepitope algorithm  twelve regions bearing putative antigenic   immunogenic determinants were detected   using   stringent threshold  these regions   probably less constrained than other parts     molecule   therefore   readily accessible   proteolysis an event   precedes  cell epitope presentation   association   mhc molecules  mediumsized peptides corresponding     12 identified regions were synthesized ten   them belong     external nterminal portion   gd gd129 gd2252 gd4982 gd77104 gd96123 gd121152 gd146179 gd176206 gd200234   gd228257 one lies adjacent     hydrophobic membrane anchor domain   gd gd287317   one   part     proposed hydrophilic cterminal cytoplasmic portion   gd gd332358   should   noted       12 predicted regions six mapped   nonglycosylated regions   gd gd129 gd4982 gd146179 gd228257 gd287317   gd332358  peptides containing predicted gd epitopes elicited potent cd4   cells   mice   diverse mhc backgrounds   cell immunogenicity studies     selected gd peptides emulsified     misa720 adjuvant were carried out   h2b h2d   h2k mice   an initial experiment   investigated   optimal dose response   peptide gd129   found   differences between doses   50 100   200 mug subsequent experiments used 100 mug   day 0   50 mug   day 21   each peptide peptidespecific  cell responses were determined   both   spleen     lymph node cells depending     peptides   strain   mice used significant  cell proliferative responses were generated   every gd peptide thus each     12 chosen regions contained   least one  cell epitope    strongest  cell responses were directed primarily although   exclusively against five peptides gd129 gd4982 gd146179 gd228257   gd332358    cell responses   h2b h2d   h2k mice were focused     same three peptides gd4982 gd146179   gd332358 suggesting     contain dominant  cell epitopes    contrast gd200234   gd228257 appeared     genetically restricted   h2d mice   levels    cell response were relatively high     deltacpm   10000   most peptides   up   50000 cpm   gd332358  although relatively moderate compared   those     remaining gd peptides   responses   gd2252 gd77104   gd96123 were also significant    peptide derived     region gd257287 peptide gd253278   was   picked     tepitope program   containing   potential  cell epitope did   induce any  cell response   any     strains   mice used   specificity     proliferative responses was ascertained     lack   response after restimulation     cells   an irrelevant peptide gb141165      lack   response   adjuvantinjected control mice data   shown  cd4   cells     cd8   cells were important  these responses were abolished     mab against cd4 molecules         mab against cd8  collectively these results indicate   gd4982 gd146179 gd228257   gd332358 peptides   highly immunogenic   contain   least one immunodominant cd4  cell epitope  priming   multiple   elevated  cell responses   pools   gdderived peptides    ability   pools   gd peptides   simultaneously induce multiple   cells specific   each peptide within   pool was explored   these experiments   immunogenicity   h2d mice   pooled versus individual peptides was compared side   side   investigate     was any agonistic   synergistic interaction between   peptide epitopes composing   pool     control h2d mice were injected   misa720 alone immunization     pool   gd129 gd4982   gd332358 peptides generated multiepitopic   significantly   elevated  cell responses specific   each peptide p  0001  thus when evaluated individually each peptide induced   relatively lower response p  0001      similar experiment   responses induced     pool   gd96123 gd146179   gd287317 peptides were also   higher than   responses induced when individual peptides were employed data   shown  several selected gd epitope peptides were identified   targets   ifngamma   il2secreting cd4   cells    determine   subset   cd4   cells induced   each gd peptide   studied   pattern   peptidespecific il2 il4   ifngamma cytokines   shown   fig  five profiles   cytokines were found   peptides gd129 gd4982 gd96123 gd146179 gd228257   gd332358 induced strong th1 cytokine ifngamma   il2 secretion   efficiently than did   remaining peptides ii   gd287317 peptide induced low levels   th1 cytokine secretion iii   gd2252   gd77104 peptides preferentially induced th2 cytokine il4 iv   gd200234 peptide induced   mixed ifngammail4 response since both cytokines were induced     comparable extent   v finally   gd121152   gd176206 peptides did   induce production   il2 il4   ifngamma cytokines  overall most peptides induced ifngamma   il2 production indicating     selected hsv1 gd peptides emulsified     misa720 adjuvant preferentially elicited   polarized th1 immune response  antibody blocking    cell activity revealed   these cytokines were mainly produced   cd4   cells   only slightly   cd8   cells     cells induced   gdpeptides react     native viral protein  experiments were performed   determine   cd4   cells induced   gd synthetic peptides were reactive   naturally processed epitopes   presented   hsv1infected cells cd4  cell lines specific   gd129 gd4982 gd146179 gd228257   gd332358 immunodominant th1 epitopes       gd77104 subdominant epitope were established   h2d mice recognition   autologous bone marrowderived dc infected   uvinactivated hsv1   each   these  cell lines was   monitored     proliferation assay   cell lines specific   gd129 gd4982 gd146179 gd228257   gd332358 recognized uvinactivated hsvinfected dc   response was observed when autologous mockinfected dc were employed   agpresenting cells   cd4  cell line induced   subdominant gd77104 peptide also failed   recognize hsvinfected dc  overall these results indicated   processing   presentation     epitopes contained     gd129 gd4982 gd146179 gd228257   gd332358 peptide sequences occurred   hsvinfected cells   subsequent experiments  cell proliferation   ifngamma production   immune   cells   gd peptideimmunized mice were monitored against whole hsv   ag   using immune spleen cells     source   responding   cells   agpresenting cells   cells   h2b h2d   h2k mice immunized   gd4982 gd146179 gd228257   gd332358 exhibited significant proliferation    ifngamma production  upon   vitro stimulation   heatkilled hsv1 under   same conditions   cells     adjuvantinjected control mice did   respond   heatinactivated hsv1stimulation  thus these responses were ag specific   were   due     mitogenic effect   viral particles these hsv1specific  cell responses were strongly reduced   anticd4 mab treatment       anticd8 mabs   lack   immunodominance   hsvprimed  cell responses   selected gdpeptides    determine   fine specificity   broadly reactive   cells associated   viral immunity     explore immunodominance     context   hsv infection proliferation   primed   cells obtained   20 hsv1infected h2d mice were evaluated against gd   using each     12 peptides   ag  although   selected peptides stimulated moderate gdspecific  cell responses surprisingly     vivo hsvprimed   cells were reactive   vitro   up   10     12 gd peptides depending     individual mouse despite   difference between individual mice   broad range   gdspecific   cells were primed         20 infected mice     unique array    cell responses was identified   each     20 infected mice analyzed  seven peptides gd129 gd4982 gd96123 gd146179 gd228257 gd287317   gd332358 induced   response     than 85     hsvinfected mice    responses were found     immunodominant epitopes gd129 gd4982 gd146179 gd287317   gd332358   also   gd2252 gd77104 gd96123   gd121152   represent subdominant epitopes  immunization     pool     newly identified cd4 th1 immunodominant gd peptide epitopes resulted   prolonged survival upon   lethal hsv1 challenge    investigate whether   th1   th2type immune responses     important   protection   hsv1 infection mice were immunized   either cd4 th1 peptide epitopes gd4982 gd146179 gd228257   gd332358   cd4 th2 peptide epitopes gd2252 gd77104 gd200234   gd287317    previously described protective epitope gd129  was excluded   these experiments groups   10 h2d mice were immunized twice     following   pool   gd4982 gd146179 gd228257   gd332358 emulsified   misa720 adjuvant     pool   gd2252 gd77104 gd121152   gd200234 emulsified   misa720 adjuvant   misa720 alone adjuvantinjected control     were left untreated nonimmunized control twenty days after   second dose   peptide vaccine mice were challenged   2 x 105 pfu     mckrae strain   hsv1 per eye   described   materials   methods mice were monitored   4 weeks after ocular hsv1 challenge   their ability   withstand   lethal infection   hsv1       mice   died following challenge did   between days 8   12 postinfection       h2d mice immunized     pool   th1 peptide epitopes survived   lethal hsv1 challenge   contrast less than 50     h2d mice immunized     pool   th2 peptide epitopes survived only 10   adjuvantinjected   10   nonimmunized control h2d mice survived   hsv1 challenge  these results demonstrate     th1 peptide epitopes provided   protection against lethal ocular hsv1 challenge than did   th2 peptide epitopes p  00003  depletion   cd4   cells abolishes   protective response    determine   involvement   cd4   cd8   cells   induced protection mice were immunized   gd4982 gd146179 gd228257   gd332358 peptides   were   divided into 4 groups   10   groups were   either depleted   cd4   cells depleted   cd8   cells left untreated none   treated   irrelevant antibodies rat immunoglobulin g igg   igg control   four groups were   challenged   hsv1   described above depletion   cd4   cells resulted     death     infected mice table  p  00001 however depletion   cd8   cells   injection   control rat igg antibodies did   significantly impair   induced protective immunity p  047   1 respectively  these results demonstrated       system cd4   cells   required   cd8   cells     sufficient   protective immunity against lethal ocular hsv1 challenge
12915561.txt 6 hsv infection     major cause     spectrum   morbidity   clinical diseases   humans  during   last decade hsv vaccine development has primarily focused   various forms   recombinantly expressed glycoproteins      11 known hsv glycoproteins gd     most highly conserved     most antigenically crossreactive between hsv1   hsv2  gd has emerged   an excellent candidate ag   inducing   protective immunity   animal models against ocular   genital infections   both types   hsv    has recently been reported     large human genital hsv trial   immunization   recombinant gd induced significant protection   women who were seronegative   hsv   was ineffective   seropositive women     men    antibody response     vaccine was similar   natural hsv infection   demonstration   its ability   induce  cell responses was restricted     limited knowledge   gd  cell epitopes    identification   molecular characterization     cd4  cell epitope repertoire   gd would contribute     better understanding     immune correlates   protection   would help   developing effective immunotherapeutic   immunoprophylactic strategies     three principal findings     present report first   combined approach   epitope prediction performed   using   tepitope algorithm     rapid determination   immunogenicity   mice     wide range   mhc restriction proved       useful strategy   identifying  cell epitopebearing regions     sequence     key immunogenic hsv protein second appropriate mediumsized peptides carefully selected     putative gd sequence   emulsified     humancompatible adjuvant misa720 mainly induced potent ifngamma   il2secreting cd4   cells   recognized naturally processed epitopes third     particular interest immunization     pool   newly identified cd4 th1 gd peptide epitopes elicited   cd4dependent protective immunity against   lethal ocular hsv1 challenge among   advantages   an epitopebased vaccine approach over   conventional wholeprotein approach     possibility   including multiple immunodominant   subdominant epitopes   strategy may offer an opportunity   elicit responses superior     induced following hsv infection   even following immunization   recombinantly expressed glycoproteins several gd peptide epitopes selected     present study induced potent hsvspecific cd4 th1like  cell responses   production   high levels   ifngamma   il2 cytokines   play   significant role   host response   hsv    addition   demonstrated an enhancement     immunogenicity   gd peptides injected     pool supporting   concept   combining potent immunogenic epitopes may     practical way   create   broader       potent  cell response numerous potential  cell epitopes could theoretically   generated     protein ag however   practice   cells tend   focus upon just   few immunodominant epitopes whereas discrete cryptic epitopes remain hidden     immune system  identification   such immunogenic epitopes   among   often hundreds   thousands   amino acids comprising hsv proteins could     cumbersome   laborious process  traditional approaches   identifying such epitopes   among   often hundreds   thousands   amino acids   cover   entire sequence     protein ag have generally involved synthesizing scores   overlapping peptides overlappingpeptide method   extensive screening    cell clones isolated   whole agstimulated cells    overlappingpeptide method might   automatically map   same epitope peptides predicted     study   using   tepitope algorithm indeed using   overlappingpeptide method one can imagine     regions where these peptides overlap might   themselves contain junctional epitopes  shortening   lengthening   peptide   one     few amino acids might sometime result   missing junctional epitopes   might   present     overlapping regions   addition   major drawback     overlappingpeptide method     number   peptide sequences   need     synthesized   tested thus making   an expensive laborintensive   timeconsuming process    addition progress     mapping    cell epitopes has been slow due   reliance   studies   clones an approach   generally involves extensive screening    cell precursors isolated   whole agstimulated cells  candidate  cell peptide epitopes can   also screened based   their affinity   interact   vitro   hla class ii molecules  however   high polymorphism   hla class ii molecules     major drawback     identification   cd4  cell epitopes   large population coverage  another alternative   cloning   cells has employed   elegant technology   tetramerguided epitope mapping   offers   opportunity     straightforward cloning     agspecific   cells through singlecell sorting  however besides needing   form pools   overlapping peptides     technology     concerns   relevant peptides present     pool     competed out   irrelevant peptides   addition   relative instability   mhc class ii tetramers compared   mhc class   tetramers points out     tetramer approach still needs improvement  relatively laborious strategies identified small subsets   candidate epitopes   sequencing peptides eluted   purified mhc molecules   pathogeninfected cells     testing their mhc binding affinity  highaffinity peptides     tested   their ability   induce pathogenspecific   cells  murine class iirestricted th lymphocyte epitopes have been described   crossreacting   hladr molecules highlighting   feasibility   murine models   evaluating epitopebased vaccines destined   human use      study reported here   allow reduction     number   peptides     cells     assayed   employed   tepitope algorithm    quickly identify regions bearing potential  cell epitopes     sequence   hsv1 gd    cell immunogenicity   selected epitopes was verified   mice   diverse mhc haplotypes   predictive power     present strategy was evaluated   comparing   tepitopeidentified regions     published  cell epitopes   hsv1   hsv2 gd proteins   latter epitopes were identified   other methods eg overlapping peptides   truncated forms   gd protein   other algorithms eg prediction   amphipathic   hydrophilic parameters    present strategy accurately identified regions bearing       previously reported gd epitopes gd123  gd241260    gd290314    importantly   present approach identified several novel   previously described th1 immunodominant cd4  cell epitopes   elicited protective immunity hsvprimed   cells induced   mice following hsv1 infection were found   recognize nearly       selected gd peptides   supports   concept   extensive diversity     array   gd epitopes being recruited during hsv infection    selected peptides were immunogenic   mice   diverse mhc backgrounds   most showed high immunogenicity   rabbits   well l benmohamed unpublished data these  cell epitopes were thus promiscuously recognized     broad variety    cell receptor molecules   diverse mhc haplotypes   careful comparative analysis     location     broadly reactive peptides within   hsv1 gd sequence revealed two relevant characteristics   most     immunogenic   epitopes were segregated   two regions within either   nterminal     cterminal domain   gd while multiepitopes corresponding   different mhc restrictions have been observed   relatively small regions   other protein ags    ii most     identified peptide epitopes were confined   nonglycosylated regions   gd      consistent     possible structural influence   glycosylation   suppressing   development   herpesspecific  cell responses   some  yetundefined process   has been recently reported   simian immunodeficiency virus glycoproteins  accumulating evidence   both animal models   humans indicates   cd4  cell immunity   directly   indirectly related     control   hsv infection  mice   depressed cd4   cells   prone   develop severe herpetic diseases   mortality upon hsv challenge  often severe ocular   genital herpetic infections   seen   immunocompromised individuals   impaired  cell immunity     true   aids   transplant patients where   immune defect   predominantly dependent upon cd4   cells  while     believed   cd4  cell responses   important   protection   general   th1   th2type immune response correlates   protection   hsv1 infection   poorly understood     present study   investigate   role   th1   th2type immune responses mice were immunized either   cd4 th1   cd4 th2 peptide epitopes   an effort   polarize   immune response   new cd4 th1 peptide epitopes   gd     th2 peptide epitopes induced   cd4dependent protective immunity against   lethal ocular hsv1 challenge   result supports an important role   th1 cd4   cells   antiherpes immunity  however because cd4 cells play an important role   supporting both b   cd8 cell function    cannot rule out   abs   cytotoxic   lymphocytes contributed     observed protection   both might have been indirectly affected     vivo depletion   cd4   cells    possible role   ab response   supported     finding   many     selected gd peptides     study were also found   induce strong antibody responses benmohamed unpublished   addition some     immunizing peptides eg gd228257   d332358 contain   previously described linear bcell epitopes  however     unlikely   preexisting antibody specific   these immunizing peptides   have   major effect since cd4 depletion was done after antibody response     peptides occurred   before   boost   these antibodies would have happened following   hsv1 challenge
12915561.txt 7 agspecific  cell proliferation induced   balbc h2d c57bl6 h2b   c3hhej h2k mice following immunization   tepitopeselected gd peptides agspecific  cell proliferation induced   balbc h2d c57bl6 h2b   c3hhej h2k mice following immunization   tepitopeselected gd peptides mice were immunized     peptide indicated     top   each panel   peptidespecific  cell responses were determined following   vitro stimulation   spleen   cells     recall peptide solid symbols     irrelevant control peptide gb141165 open symbols   spleen   cells were obtained   h2d circles h2b triangles   h2k squares mice 14 days after   second final immunization   means  standard deviations   two separate experiments five micegroupexperiment   shown
12915561.txt 8 simultaneous induction   multiple agspecific   cells   pools   gdderived peptides simultaneous induction   multiple agspecific   cells   pools   gdderived peptides h2d mice were immunized     pool   gd129 gd4982   gd332358       individual peptides   peptides indicated above each panel were used     vitro stimulation   spleen   cells   mice immunized     pooled peptides solid squares mice immunized   individual peptide open squares   control mice injected   adjuvant alone open circles   results shown   representative   three separate experiments   p values shown     pooled versus single peptide
12915561.txt 9 induction   il2 il4   ifngamma   gd peptides emulsified   misa720 adjuvant induction   il2 il4   ifngamma   gd peptides emulsified   misa720 adjuvant h2d mice were immunized   individual peptides   described splenic   cells were stimulated     immunizing peptide solid bars     control irrelevant peptide gb141165 open bars il2 il4   ifngamma secreted into   culture media were quantified     specific sandwich enzymelinked immunosorbent assay   described   materials   methods
12915561.txt 10   gd peptideinduced  cell responses were relevant     native viral protein   gd peptideinduced  cell responses were relevant     native viral protein   splenocytederived cd41 cell lines   gd129 gd4982 gd77104 gd146179 gd228257   gd332358immunized h2d mice were incubated   autologous bone marrowderived dc   an effector target ratio     cells   dc   501 target dc had been infected   uvinactivated hsv1   an moi   3 1 03   01 hsv infected dendritic cells control cultures contained cd41   cells   mockinfected dc   3hthymidine uptake   observed   three independently performed experiments   shown b proliferative responses   cd41   cells   h2d closed circles h2b closed triangles   h2k closed squares mice immunized   gd4982 gd146179 gd228257   gd332358 gd peptides were determined   using heatkilled hsv1   an moi   3 1 03 01 003   001     vitro stimulation 3hthymidine incorporation was determined after 3 days   stimulation spleen cells   adjuvantinjected h2b open circles h2d open triangles   h2k open squares mice were used   control
12915561.txt 11   predicted peptides contain epitopes     naturally processed   presented     host immune system during   course   hsv infection   predicted peptides contain epitopes     naturally processed   presented     host immune system during   course   hsv infection   cells   spleens   h2d mice 21 days after hsv1 infection recognized   selected gd peptides   determined     vitro lymphoproliferative responses   individual peptide hsv1 infected spleen cells   mockinfected mice were used   controls
12915561.txt 12 peptides bearing potential  cell epitopes identified within   hsv1 glycoprotein   gd   using   tepitope algorithm
12915561.txt 13 cd4 dependence    cell proliferation   cytokine secretion induced   gd peptides
12915561.txt 14 immunization   newly identified th1 gd peptide epitopes     misa720 adjuvant confers protective immunity     lethal hsv1 challenge
12915561.txt 15 immunization     newly identified gd peptide epitopes     montanide adjuvant induced   cd4 celldependent protective immunity against   lethal hsv1 challenge
12915561.txt 16 
